How Do PE-Backed Companies Scale from AI Pilot to a Platform-Wide Program? A 3-Phase Coordination Framework

How Do PE-Backed Companies Scale from AI Pilot to a Platform-Wide Program? A 3-Phase Coordination Framework

Most PE-backed companies deploying AI in one or two functions find themselves stuck in the same spot a year later. Here is the 3-phase path out.

Published

Last Modified

Topic

AI Adoption

Author

Jill Davis, Content Writer

TLDR: Most PE-backed companies that have deployed AI in one or two functions find themselves in the same position twelve to eighteen months later: the pilot is running, the results are encouraging, and nothing else has been automated. The gap between a functioning AI pilot and a coordinated platform-wide program is not a technology gap. It is a measurement, sequencing, and governance gap. This post covers the three structural problems that keep AI pilots from scaling, what a platform-wide automation program actually looks like, and how to use early wins as the foundation for a broader value creation strategy.

Best For: CEOs, COOs, and operating partners at PE-backed platforms that have deployed AI in at least one function and are trying to understand why it hasn't scaled — or who want to build a coordinated automation program before the pilot phase runs too long.

Twelve to twenty-four months into AI adoption, many PE-backed companies land in the same position. The scheduling bot is working. The RCM automation vendor is live. The document processing tool has been deployed in one department and the results look good. But nothing else has been automated. The ROI from the initial deployment has not been rigorously measured. The board is starting to ask what AI is worth to the business, and the honest answer — if management is being candid — is that nobody has run the numbers.

The technology is usually fine. The problem is structural. AI pilots start as department-level initiatives responding to specific pain points, without a platform-wide framework for measuring or sequencing additional automation. The pilot succeeds. The broader program never gets built because nobody established the conditions for it: a cross-functional view of automation opportunities, a measurement infrastructure to track ROI, a governance structure to make investment decisions.

The gap between a functioning pilot and a coordinated program is an organizational design problem. That is what makes it persistent, and that is what makes it fixable.

The Three Structural Reasons AI Pilots Don't Scale

1. No Baseline Measurement Before or After Deployment

The most common reason a company cannot answer the question "is our AI delivering ROI?" has nothing to do with whether the AI is working. It is that nobody measured the baseline before deployment, and there is no consistent KPI framework tracking performance after. The pilot was evaluated on qualitative feedback and activity metrics — the tool processed X transactions, staff said it saved them time — rather than on quantified business outcomes.

Without a baseline, improvement is invisible. If the scheduling bot was deployed without measuring the before-deployment conversion rate on after-hours calls, there is no way to calculate how much incremental revenue the bot has generated. If the RCM tool was implemented without establishing pre-automation days-in-A/R and denial rate figures, there is no way to know whether those metrics have improved and by how much.

This measurement gap has two consequences. First, the ROI of the initial deployment cannot be demonstrated to the board, which makes it harder to fund the next automation. Second, the platform has no data on which implementation choices worked and which didn't — making the design of the next automation a guess rather than an informed decision.

2. No Sequencing Logic Connecting Workflows

AI pilots start in a single function because a specific problem was visible and a specific vendor offered a solution. The scheduling team had a conversion problem. An automation vendor pitched a scheduling bot. The pilot worked. But nobody asked the question: what workflows are upstream and downstream of scheduling, and does automating scheduling without touching those workflows create a new bottleneck?

In any service business, administrative workflows are connected. Scheduling volume feeds intake and verification volume. Intake and verification quality feeds authorization or pre-approval volume. Authorization volume feeds billing submission volume. Billing submission quality feeds denial management volume. Deploying automation in one stage of this chain without considering its effect on adjacent stages produces predictable problems: the automated stage accelerates, the manual stages downstream become the constraint, and the ROI of the automation is partially consumed by the added cost of the bottleneck it created.

A physical therapy platform that automates scheduling without automating prior authorization processing will find that increased appointment volume generates a prior authorization backlog. Each additional appointment requires an authorization submission, and if those submissions are still being processed manually, the prior authorization team becomes overwhelmed. The gain from the scheduling automation is offset by the cost of expanded authorization staff — not because the scheduling automation failed, but because the sequencing logic was wrong.

Scaling from one AI pilot to a platform-wide program requires sequencing logic that accounts for workflow dependencies — which means starting with a cross-functional map of how administrative processes connect before deciding what to automate next.

3. No Governance Structure for Cross-Functional AI Investment Decisions

Departmental AI pilots are owned by departments. The scheduling team owns the scheduling bot. The revenue cycle team owns the RCM vendor. These decisions are made by the functional leaders closest to the problem, which is appropriate for pilot-stage initiatives.

But scaling to a platform-wide program requires cross-functional investment decisions: which automation should be funded next across a portfolio of competing options from different departments? Which vendor relationships should be consolidated? Which workflows should be sequenced together because of their dependencies? These decisions cannot be made by individual functional leaders, because each leader has visibility into their own domain and a natural incentive to prioritize it.

Without a governance structure — an owner, a decision-making process, and a shared investment framework — the platform's AI program remains a collection of departmental initiatives rather than a coordinated value creation strategy. Automation investments continue to be made reactively, ROI continues to go unmeasured, and the cumulative value from AI stays well below what a coordinated approach would produce.

What a Platform-Wide Automation Program Actually Looks Like

A platform-wide automation program is not bigger or more expensive than a collection of point solutions. In many cases, it costs less — because a coordinated approach reduces vendor duplication, eliminates automations that were deployed out of sequence and are underperforming, and focuses investment on the highest-ROI opportunities rather than the most recently requested ones.

The program has four components: a cross-functional workflow map, a shared ROI framework, a sequenced roadmap, and a governance structure.

The cross-functional workflow map is a current-state picture of how administrative labor is distributed across the business at the process level. Not an organizational chart — a process-level accounting of who does what, how long each step takes, and where errors occur. This is the foundation for everything else. Without knowing where labor cost is actually concentrated, investment decisions are made on instinct rather than evidence.

The shared ROI framework establishes the KPIs that will be tracked for every automation initiative — before and after deployment — and a consistent methodology for calculating savings, revenue impact, and cash flow improvement. This framework makes the ROI of every automation initiative visible and comparable, which is what makes it possible to prioritize across a portfolio of options. In healthcare platforms, for instance, the standard framework tracks scheduling utilization, prior authorization denial rates, days in A/R, and administrative cost per patient visit — across all sites, on a consistent definition — rather than having each site report its own metrics in its own format.

The sequenced roadmap is the prioritized list of automation initiatives, ordered by their combination of ROI impact and implementation complexity, with workflow dependencies accounted for. It is organized into phases — quick wins in the first quarter, core automation in quarters two and three, revenue optimization in quarters three and four — with specific dollar targets and measurement checkpoints for each phase.

The governance structure is a cross-functional operating model for making AI investment decisions: who has authority to approve new automation initiatives, how competing priorities are resolved, and who is responsible for measuring and reporting on program performance. For most platforms, this is a lightweight structure — a monthly review meeting with representation from operations, finance, and IT, with a clear decision framework rather than a consensus process — not a separate committee or organizational layer.

How to Use Existing AI Wins as the Foundation

Platforms that have already run one or two successful pilots are well-positioned to build a coordinated automation program — because they have real data on what implementation looks like in their specific environment, rather than having to rely on industry benchmarks and vendor claims.

A scheduling bot that was deployed for after-hours use and subsequently expanded to 24/7 operation is a data source: it tells you the conversion rate improvement the automation produced, the volume of appointments it generates, the staff hours it displaced, and what the implementation required in terms of systems integration, change management, and operational adjustment. That data is the foundation for modeling the ROI of the next automation, because it is calibrated to your specific operation rather than industry benchmarks.

Similarly, an RCM automation vendor that is live but partially deployed is typically the highest-ROI near-term opportunity: finish implementing the capabilities already purchased before signing new contracts. Enterprise vendor agreements in revenue cycle, scheduling, and patient or customer management consistently include capabilities that were purchased but never enabled — either because the implementation scope was narrower than the contract, or because staff turnover removed the institutional knowledge of what was available. Auditing existing vendor utilization before adding new vendors is a standard first step in building a coordinated program.

The Measurement Infrastructure Question

Building a platform-wide automation program requires aggregate visibility into operational performance across sites. In most multi-site businesses, this visibility doesn't currently exist in a useful form. Each site reports its own metrics, often in different formats and on different definitions. Finance sees the consolidated P&L. Operations sees site-level snapshots. Nobody has a cross-site view of scheduling utilization, administrative denial rates, or cost per transaction that would make the ROI of automation visible at the platform level.

Building this measurement infrastructure is technically straightforward. It typically requires connecting three or four data sources — the scheduling system, the billing system, the EHR or CRM, and whatever automation tools are already deployed — into a shared reporting layer that produces consistent metrics across sites. For most platforms, this is a four-to-eight-week implementation, not a multi-year data warehousing project.

The value of this infrastructure is not just measurement. It is accountability. When the platform-wide automation program has a shared measurement framework, every automation initiative has a clear performance standard — and underperforming initiatives can be identified and addressed before they consume ongoing license and operational costs.

What PE Investors Should Expect From an AI Value Creation Program

For operating partners and investors evaluating whether a portfolio company's AI program is creating real value, the diagnostic question is straightforward: can management produce a before-and-after comparison of the operational KPIs the automation was designed to move?

If the answer is no — if management can confirm that automation is deployed but cannot produce the baseline metrics, the current metrics, and a calculation of the improvement — the program is being run as a technology initiative. That is a different thing, with a much less reliable path to the P&L.

The goal of a coordinated AI and automation program is not to maximize the number of tools deployed. It is to maximize the measurable improvement in operating efficiency and revenue generation — and to be able to show, specifically and quantitatively, that the AI program is responsible for that improvement. That discipline is what separates AI programs that appear in EBITDA from those that appear in the technology budget line.

Assembly helps PE-backed platforms build coordinated AI and automation programs — from diagnostic through implementation — with measurement infrastructure built in from day one. If your platform has AI pilots that haven't scaled into a broader program, we'd welcome a conversation about what building that program looks like.

Your AI Transformation Partner.

Your AI Transformation Partner.

© 2026 Assembly, Inc.